Expression of a breast-cancer-associated protein (pS2) in human neuro- endocrine tumours

International Journal of Cancer

Volumn 74, Issue 3, 1997, Pages 270-274

  Wang, Da Gong ^a,b   Johnston, Colin F ^a   Liu, Wei Hua ^a   Sloan, James M ^a   Buchanan, Keith D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ANTIBODY SPECIFICITY; ARTICLE; BREAST CANCER; CAROTID BODY TUMOR; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; SECRETORY GRANULE; STOMACH MUCOSA;

ADRENAL GLAND NEOPLASMS; BLOTTING, NORTHERN; CARCINOID TUMOR; CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PHEOCHROMOCYTOMA; PITUITARY NEOPLASMS; PROTEINS; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEINS;

EID: 0030750550     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970620)74:3<270::AID-IJC6>3.0.CO;2-W     Document Type: Article

References (18)

1. NAKAMORI, S. and TATEISHI, R., Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Europ. J. Cancer. 30A, 702-797 (1094).
2. HOOSEIN, N.M., THIN, L., JORGENSEN, K.H. and BRATTAIN, M.G., Growth-stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon-and breast-tumour cells. FEBS Lett., 247, 303-306 (1989).
3. JOHNSTON, C.F., O'NEILL, A.B., O'HARE, M.M.T. and BUCHANAN, K.D., Neuro-endocrine cell within colorectal tumours induced by dimethylhydrazine. Cell Tissue Res., 246, 205-210 (1986).
4. KLÖPPEL, G. and HEITZ, P.U., Diffuse endocrine-cell system-morphology and functional activity of gastorenteropancreatic neuroendocrine tumours. Recent Results Cancer Res., 118, 27-36 (1990).
5. LUFEBVRE, O., CHENARD, M.P., MASSON, R., LINARES, J., DIERICH, A., LEMEUR, M., WENDING, C., TOMASETTO, C., CHAMBON, P. and RIO, M.C., Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science, 274, 259-262 (1996).
6. MASIAKOWSKI, P., BREATHNACH, R., BLOCH, J., GANNON, F., KRUST, A. and CHAMBO, P., Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast-cancer cell line. Nucleic Acids Res., 10, 7895-7903 (1982).
7. MOODY, T.W. and CUTTITTA, F., Growth factor and peptide receptors in small-cell lung cancer. Life Sci., 52, 1161-1173 (1993).
8. MÜLLER, W. and BORCHARD, F., pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival. J. Pathol., 171, 263-269 (1993).
9. NILLSON, O., WANGBERG, B., KOIBY, L., SCHULTZ, G.S. and AHLMAN, H., Expression of transforming growth factor alpha and its receptor in human neuro-endocrine tumours. Int. J. Cancer, 60, 645-651 (1995).
10. NUNEZ, A.M., BERRY, M., IMLER, J.L. and CHAMBON, P., The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J., 8, 823-829 (1989).
11. RIO, M.C., BELLOCQ, J.P., DANIEL, J.Y., TOMASETTO, C., LATHE, R., CHENARD, M.P., BATZENSCHLAGER, A. and CHAMBON, P., Breast-cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science, 241, 705-707 (1988).
12. RIO, M.C., BELLOCQ, J.P., GAIRARD, B., RASMUSSEN, U.B., KRUST, A., KOCHI, C., CALDEROLI, H., SCHIFF, V., RENAUD, R. and CHAMBON, P., Specific expression of the pS2 gene in sub-classes of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. nat. Acad. Sci. (Wash.). 84, 9243-9247 (1987).
13. RIO, M.C., CHENARD, M.P., WOLF, C., MARCELLIN, L., TOMASETTO, C., LATHE, R., BELLOCQ, J.P. and CHAMBON, P., Induction of pS2 and hSP genes as markers of mueosal ulceration of the digestive tract. Gastroenterology. 100, 375-379 (1991).
14. SUZUKI, T., WATANABE, K., SUGINO, T., TANIGAWA, T. and SATOH, S., Immunocytochemical demonstration of IGF-II immunoreactivity in human phaeochromocytoma and extra-adrenal abdominal paraganglioma. J. Pathol., 167, 199-203 (1992).
15. WANG, D.G., BARROS D'SA, A.A.B., JOHNSTON, C.F. and BUCHANAN, K.D., Oncogene expression in carotid-body tumours. Cancer. 77, 2581-2587 (1996).
16. WELTER, C., THEISINGER, B., RIO, M.C., SEITZ, G., SCHUDER, G. and BLIN, N., Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumours. Int. J. Cancer. 56, 52-55 (1994).
17. WELTER, C., THEISINGER, B., SEITZ, G., TOMASETTO, C., RIO, M.C., CHAMBON, P. and BLIN, N., Association of the human spasmolytic polypeptide and an estrogen-induced breast-cancer protein (pS2) with human pancreatic carcinoma. Lab. Invest., 6, 187-192 (1992).
18. WRIGHT, N.A., POULSOM, R., STAMP, G., NOORDEN, S.V., SARRAF, C., ELIA, G., AHNEN, D., JEFFEY, R., LONGCROFT, J., PIKE, C., RIO, M.C. and CHAMBON, P., Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 104, 12-20 (1993).